Organ System

Cardiovascular

Endocarditis Therapy

• Guidelines for the management of infective endocarditis (ESC 2015) 
   
• Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the working party of BSAC (2012)
   
• Update on cardiovascular electronic implantable device infections and their management: A scientific statement from the American Heart Association (2010) [PDF]

Endocarditis Prophylaxis

• Prophylaxis against infective endocarditis: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedure (NICE 2008; Updated July 2016)
  

Neurological

Meningitis

• UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults (BIA - JoI 2016)
  
  
• Early management of suspected meningitis and meningococcal sepsis in immunocompetent adults (3rd edition, Jan 2016)
   
• Bacterial meningitis and meningococcal septicaemia: Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care (NICE 2010) Updated 2015

Encephalitis

• *Management of suspected viral encephalitis in adults (BIA - JoI 2012) 
   
• *Management of suspected viral encephalitis in children (BIA - JoI 2012)

Respiratory

• Cough (acute): antimicrobial prescribing
• Flu vaccination: increasing uptake

Pneumonia

• Pneumonia in adults: diagnosis and management (NICE 2014)
• 2015 - Annotated BTS guideline for the management of CAP in adults (2009) 
• Guidelines for the management of community-acquired pneumonia in children (BTS 2011 update)
• Pneumonia (community-acquired): antimicrobial prescribing
• Pneumonia (hospital-acquired): antimicrobial prescribing

Urinary

Urinary Tract Infections

• Urinary tract infection in under 16s: diagnosis and management (NICE 2007) Reviewed 2013

• Diagnosis, prevention, and treatment of catheter-associated urinary tract infections in adults: 2009 international clinical practice guidelines from IDSA [PDF]

Cystitis

• International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women (IDSA and ESCMID 2010 Update)

 

Organism

Bacteria

Anthrax

• Guidelines: Cutaneous and Inhalation anthrax (National Archives 2012)

• Guidelines: Anthrax in heroin users (National Archives 2012)

Carbapenemase-producing Enterobacteriacea

• Carbapenemase-producing Enterobacteriacea: early detection, management and control toolkit for acute trusts (PHE 2014)                                       

Clostridium difficile infection

• HPS Guidance on prevention and control of Clostridium difficile infection (CDI) in health and social care settings in Scotland (HPS Sept 2017)

• Update of the treatment guidance document for Clostridium difficile infection (ESCMID 2014)

• Clostridium difficile infection: guidance on management and treatment (PHE 2013)

Diptheria

• Public health control and management of diphtheria (in England and Wales) (2015)

Group A streptococcal infection

• *Group A Streptococcus - guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK (BIA; JoI 2012) 

Helicobacter pylori

• *Helicobacter pylori in dyspepsia – quick reference guide for primary care (BIA, HPA; Reviewed 2012) 

Lyme disease

• NICE quality standard: Lyme Disease (July 2019)

• * The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: A position statement by the British Infection Association (BIA; JoI 2011) 

• NICE guideline on Lyme disease (April 2018)

• The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis (IDSA 2006)                 

• EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis (2010) [PDF]

Multi-resistant acinetobacter

• *Working party guidance on the control of multi-resistant acinetobacter outbreaks (AMM, BSAC, HPA, HIS, ICNA, DH 2006)

Multi-resistant Gram-negative bacteria

Pertussis

• Guidelines for the public health management of pertussis (PHE 2012) [PDF]

Staphylococcus aureus infection

• Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England (HPA 2008) 

Mycobacteria

Leprosy

• Memorandum on leprosy (PHE 2012) 

Tuberculosis

• ATS/IDSA Statement: diagnosis, prevention and treatment of nontuberculous mycobacterial diseases (2007)

• Tuberculosis (NICE 2016)

TB meningitis

• *BIS guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children (BIS; JoI 2009)            

Fungi

Aspergillosis

• Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management (ESCMID, ERS 2016)

• Treatment of aspergillosis: IDSA Clinical Practice Guidelines (2008)

Candida

• Guideline for the diagnosis and management of Candida diseases (ESCMID 2012)

• Clinical Practice Guidelines for the treatment of candidiasis (IDSA 2009 Update)  

Blastomycosis

• Clinical Practice Guidelines for the management of blastomycosis (IDSA 2008 Update)

Coccidioidomycosis

• Coccidioidomycosis (IDSA 2005)             

Cryptococcus

• Clinical Practice Guidelines for the management of cryptococcal disease (IDSA 2010 Update)

Histoplasmosis

• Clinical Practice Guidelines for the management of patients with histoplasmosis  (IDSA 2007 Update)

Rare and emerging

• Guidelines on disgnosis and management of rare and emerging fungal diseases (ESCMID, EFISG, ECMM 2014)

Viruses

Hepatitis

• Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults (NICE 2013)     

• Ledipasvir-sofosbuvir for treating chronic hepatitis C (NICE 2015)

• Daclatasvir for treating chronic hepatitis C (NICE 2015)

• Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C (NICE 2015)

                                                                 

HIV

The following BHIVA guidelines are available at BHIVA.org:

• HIV-associated malignancies (2014)

• Management of HIV infection in pregnant women 2012 (2014 interim review)

• Management of hepatitis viruses in adults infected with HIV 2013 (Update Sept 2014)

• Treatment of HIV-1 positive adults with antiretroviral therapy 2015

• Routine investigation and monitoring of adult HIV-1-infected individuals (2011)

• Treatment of TB/HIV coinfection (2011)

• Treatment of opportunistic infection in HIV-seropositive individuals (2011)

• UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (PEPSE)2015

• Antiretroviral Treatment of HIV-2 Positive Individuals (2010)

• Determining HIV-1 tropism in routine clinical practice (2009)

• Use of vaccines in HIV-positive adults (2015)

• UK Guidelines for the management of sexual and reproductive health of people living with HIV infection (2008)

• UK National Guidelines for HIV Testing (2008)

Influenza

• Avian influenza: guidance and algorithms for managing human cases (PHE 2014)  

• PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza (2015-16) [PDF]

Measles

• PHE National Measles Guidelines (August 2017)

MERS CoV

• Infection control advice: Middle East respiratory syndrome coronavirus (MERS CoV) (PHE 2013) [PDF]

Norovirus

• *Guidelines for the management of norovirus outbreaks in acute and community health and social care settings (Norovirus Working Party 2012) [PDF]

Rabies

• PHE guidelines on managing rabies post-exposure (June 2018)   

Varicella

• *Chickenpox in adults – clinical management (BIS) (JoI 2008)

Viral Haemorrhagic Fevers

• Viral haemorrhagic fever: ACDP algorithm and guidance on management of patients (PHE, DH Updated 2015) 

• Ebola virus disease: clinical management and guidance (PHE, updated 2015)               

Parasites

Malaria

• Guidelines for malaria prevention in travellers from the UK
• *UK malaria treatment guidelines 2016 (JoI)

Other Guidelines

Antimicrobial Stewardship

• Antimicrobial stewardship: changing risk-related behaviours in the general population (NICE 2017)
• Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NICE 2015)

Biofilms

Cirrhosis

• Cirrhosis in over 16s: assesment and management (NICE 2016)

Chronic Fatigue Syndrome

• Chronic fatigue syndrome / myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children (NICE 2007) Currently placed on NICE static list

Diabetic Foot

• Diabetic foot problems: prevention and management (NICE 2015) 

Infection Control

• Infection Prevention and Control Commissioning Toolkit (IPS, RCN 2016)
• Healthcare-associated infections: NICE quality standard (2016)
• Infection: Prevention and control of healthcare-associated infections in primary and community care (NICE 2012) (Updated 2017)   
• Surgical site infection: Prevention and treatment of surgical site infection (NICE 2019)

Immunocompromised Host

• Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients (NICE 2012)                    

Neonatology

• Antibiotics for early-onset neonatal infection: Antibiotics for the prevention and treatment of early-onset neonatal infection (NICE 2012)  
• Group B streptococcal disease, early onset (Green –top guideline no. 36)(RCOG 2012)

Pregnancy

• Guidance on viral rash in pregnancy: investigation, diagnosis and management of viral rash illness, or exposure to viral rash illness, in pregnancy (HPA 2011) [PDF]

Sepsis

• Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012 (IDSA)  [PDF]
• Sepsis: recognition, diagnosis and early management (NICE 2016) (Updated 2017)

 

• *Fever in returned travellers presenting in the United Kingdom; Recommendations for investigation and initial management (BIA 2009) (JoI)
• *Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management (BIA 2010) (JoI)
• Clinical guidelines for immunoglobulin use (2011) [PDF]